Reactor-produced radionuclides at the University of Missouri Research Reactor

Applied Radiation and Isotopes

Volumn 49, Issue 4, 1998, Pages 295-297

  Ehrhardt, Gary J ^a   Ketring, Alan R ^a   Ayers, Lynn M ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; BONE; HOLMIUM; LUTETIUM; MONOCLONAL ANTIBODIES; POLYPEPTIDES; RADIOISOTOPES; RESEARCH REACTORS; RHENIUM; RHODIUM; SAMARIUM;

BETA EMITTERS;

RADIOTHERAPY;

HOLMIUM; HOLMIUM 166; LUTETIUM; MONOCLONAL ANTIBODY; POLYPEPTIDE; RADIOACTIVE MICROSPHERE; RADIOISOTOPE; RHENIUM 186; RHENIUM 188; RHODIUM; SAMARIUM 153; UNCLASSIFIED DRUG;

BETA RADIATION; CONFERENCE PAPER; NUCLEAR REACTOR; PRIORITY JOURNAL; RADIOTHERAPY; RECEPTOR BINDING;

NUCLEAR MEDICINE; NUCLEAR REACTORS; RADIOISOTOPES;

EID: 0032053948     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8043(97)00038-9     Document Type: Conference Paper

References (11)

1. 2. J. Nucl. Med. 36, 850-858.
2. Bayouth, J. E., Macey, D. J. and Kasi, L. P. et al.. (1995) Pharmacokinetics, dosimetry, and toxicity of holmium-166 DOTMP for bone marrow ablation in multiple myeloma. J. Nucl. Med. 36, 730-737.
3. Breitz, H. B., Durham, J. S. and Fisher, D. R. et al.. (1995) Pharmacokinetics and normal organ dosimetry following intraperitoneal rhenium-186 labeled monoclonal antibody. J. Nucl. Med. 36, 754-761.
4. Clunie, G., Lui, D., Cullum, I., Edwards, J. C. W. and Ell, P. J. (1995) Samarium-153 particulate hydroxyapatite radiation synovectomy: Biodistribution data for chromic knee synovitis. J. Nucl. Med. 36, 51-57.
5. Eary, J. F., Collins, C. and Stabin, M. et al.. (1993) Samarium-153 EDTMP biodistribution and dosimetry estimation. J. Nucl. Med. 43, 1031-1036.
6. Ehrhardt, G. J. and Day, D. E. (1987) Therapeutic use of Y-90 microspheres. Nucl. Med. Biol. 14, 233-242.
7. Ehrhardt, G. J., Ketring, A. R., Liang, Q., Miller, R. A., Holmes, A. and Wolfangel, R. G. (1995) Refinement of the peroxide process for making W-188/Re-188 and Mo-99/Tc-99m gel radioisotope generators for nuclear medicine. In Technetium and Rhenium in Chemistry and Nuclear Medicine, eds. M. Nicolini, G. Bandoli and U. Mazzi, Vol. 4. SGEditoriali, Padova, Italy.
8. Kennel, S. J. and Mirzadeh, S. (1996) Vascular Targeting for Radioimmunotherapy with Bi-213. Nucl. Div. Abstr. 021, Book of Abstracts, 212th National Meeting of the American Chemical Society, Orlando, FL.
9. Maxon, H. R. III, Schroder, L. E., Hertzberg, V. S., Thomas, S. R., Englaro, E. E., Samaratunga, R., Smith, H., Moulton, J. S., Williams, C. C., Ehrhardt, G. J. and Schneider, H. J. (1991) Re-186 (Sn) HEDP for treatment of painful osseous metastases: Results of a double-blind crossover comparison with placebo. J. Nucl. Med. 32, 1877.
10. Schott, M. E., Schlom, J. and Siler, K. et al.. (1994) Biodistribution and preclinical radioimmunotherapy studies using radiolanthanide-labeled immunoconjugates. CANCER 73, 993-998.
11. Volkert, W. A., Goeckeler, W. F., Ehrhardt, G. J. and Ketring, A. R. (1991) Therapeutic radio nuclides: Production and decay property considerations. J. Nucl. Med. 32, 174-185.